- Inspire Medical Systems ( NYSE: INSP ) shares gained as much as 5% on Monday after the medical technology company guided for Q4 revenue of $137.5M to $137.9M, representing ~76% Y/Y growth. Analysts expect the company to generate $117.43M revenue for the period .
- "We are very pleased with our strong preliminary revenue performance in the fourth quarter primarily driven by higher utilization at existing centers," said president and CEO Tim Herbert.
- The company activated 61 new centers in the U.S. in the fourth quarter, bringing the total to 905 U.S. medical centers implanting Inspire therapy. It also create 16 new sales territories in the U.S. during the period.
- Revenue for full year 2022 is anticipated to be in the range of $407.5M to $407.9M (consensus: $387.41M), an ~75% increase over full year 2021.
- Inspire Medical Systems ( INSP ) will report its full financial results for 2022 during its earnings announcement planned for February 7, 2023.
For further details see:
Inspire Medical stock rises after guiding revenue above estimates